Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo (NCT07524946)
A 12-Week, Phase 4, Open-Label Study To Assess Safety, Pharmacokinetics, and Treatment Effect of CABTREO (Clindamycin Phosphate 1.2%, Adapalene 0.15%, and Benzoyl Peroxide 3.1%) Topical Gel In Pediatric Participants Ages 9 to 11 Years, 11 Month With Acne Vulgaris
🩺 Plain-English Summary (8th-Grade Level)
This study is to evaluate the safety, pharmacokinetics, and treatment effect for topically applied CABTREO lotion in pediatric participants ages 9 to 11 years, 11 months with Acne Vulgaris.
Who can join: Review the eligibility criteria below.
Location: Dermatology Trial Associates — Bryant, Arkansas
Age range: 9 Years to 11 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (15 Sites)
- Dermatology Trial Associates — Bryant, Arkansas
- Northwest Arkansas Clinical Trials Center — Rogers, Arkansas
- Center for Dermatology Clinical Research — Freemont, California
- Ablon Skin Institute and Research Center — Manhattan Beach, California
- Ziaderm Research, LLC — North Miami Beach, Florida
- Clinical Research Trials of Florida, Inc — Tampa, Florida
- DS Research of Kentucky, LLC — Louisville, Kentucky
- Michigan Center for Skin Care Research — Clinton Township, Michigan
- JDR Dermatology Research — Las Vegas, Nevada
- DermResearchCenter of New York — Stony Brook, New York
- Vitality Clinical Trials, LLC — Woodbury, New York
- Flourish Research Acquisition, LLC — Apex, North Carolina
- Lynn Health Science Institute — Oklahoma City, Oklahoma
- Cyn3rgy Research Corporation — Gresham, Oregon
- Breakaway Research Group — Spokane, Washington
📞 Contact the Study Coordinator
Phone: (731) 415-3174
Email: Emily.Hughes@BauschHealth.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Acne Vulgaris
- Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy — Stanford, California
- A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients — High Point, North Carolina
- Lipidome and Microbiome Profile of Acne — Sacramento, California
- Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris — Calgary, Alberta
- Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne. — Sacramento, California
Explore by condition: All Acne Vulgaris clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.